SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950144-05-005044
Filing Date
2005-05-06
Accepted
2005-05-06 17:26:31
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ATHEROGENICS, INC g95117e10vkza.htm 10-K/A 511849
2 EX-31.5 SECTION 302 CERTIFICATION OF THE CEO g95117exv31w5.txt EX-31.5 3999
3 EX-31.6 SECTION 302 CERTIFICATION OF THE CFO g95117exv31w6.txt EX-31.6 4050
4 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO & CFO g95117exv32w1.txt EX-32.1 3100
5 filename5.txt CORRESP 6827
  Complete submission text file 0000950144-05-005044.txt   531163
Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Filer) CIK: 0001107601 (see all company filings)

IRS No.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31261 | Film No.: 05809164
SIC: 2834 Pharmaceutical Preparations